Suche
Mein Konto
Vienna: Emerging hotspot for life sciences and innovation!
By 2025, Vienna will establish itself as a leading life science location in Europe with a focus on innovation and sustainability.
Vienna: Emerging hotspot for life sciences and innovation!
Vienna has established itself as an important location for life sciences in Europe and is well on its way to further expanding its leading role in this dynamic sector. With a focus on sustainability, digitalization and networking, Seestadt is becoming a center for innovation and research. Several well-known companies including TAKEDA, Biomay, Enovis and SK-Telemed, have settled here, which underlines Vienna's attractiveness as a living space for research and development facilities.
Whether large companies or young start-ups – everyone will find optimal conditions for research, development and production in Vienna. An outstanding example is tech2people, Europe's largest center for robotic neurotherapy, which innovatively combines research and application. The diversity of active organizations - over 754, including 646 companies and 19 research institutions - shows the growth taking place in the life sciences industry.
Growth and innovative strength
The economic indicators for Vienna are promising: between 2020 and 2023, the life sciences industry increased its annual sales by 22% to an impressive 22.7 billion euros. The majority – around 81% or 18.4 billion euros – is in the biotechnology and pharmaceutical sectors. The number of employees is also continually increasing; over 49,000 jobs have been created in this sector.
What is particularly noteworthy is the dynamic of innovation, which is driven forward by lighthouse projects and new start-ups. For example, a new cancer research center is being welcomed by Boehringer Ingelheim as an international research and production center. In addition, the newly founded AITHYRA Institute for Artificial Intelligence in Biomedicine is a further step towards future research. Around 8,800 scientific publications were recorded in this area in 2023, which demonstrates the high active research density.
Vienna as a global hotspot
Vienna has long since developed into a global production location for key pharmaceutical products. Around 4 million liters of blood plasma are processed annually by companies such as Octapharma and Takeda, accounting for around 20% of the global volume. It is noteworthy that 95% of the drugs produced are exported from blood plasma. The city is therefore an important player not only for domestic supplies, but also internationally.
The area of biotechnological active ingredients is also flourishing. Companies like Biomay and Boehringer Ingelheim are working on lively production capacities, while start-ups like MADx and contextflow are enriching the scene with innovative products for allergy testing and AI-driven CT image analysis. In Vienna, companies like a:head and HeartBeat.bio show that the city is becoming a European hotspot for life sciences and biomedical artificial intelligence.
In summary, Vienna is not only an attractive location, but also a center for life-changing innovations. With a strong network of research institutions, companies and promising start-ups, the city is ready to take a leading role in the future of life sciences. Supporting initiatives like LISAvienna for over 20 years shows that they have a good knack for promoting emerging talent and ideas.